IMV
IMV is a clinical-stage immuno-oncology company that wants to transform the way they engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape.
IMV
Industry:
Biotechnology Health Care
Founded:
2000-01-01
Address:
Dartmouth, Nova Scotia, Canada
Country:
Canada
Website Url:
http://www.imv-inc.com
Total Employee:
11+
Status:
Active
Contact:
+1 (902) 492-1819
Total Funding:
79.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Arch Oncology
Arch Oncology is an immuno-oncology company
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Beyeonics
A Surgical visualization company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Disc Medicine
Disc Medicine is a hematology company
Endpoint Health
Precision Immunology Therapies
EpicentRx Inc
EpicentRx Inc is a clinical-stage immuno-oncology company.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
ImmuneID
ImmuneID is a precision immunology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
Medicenna Therapeutics
Medicenna is a clinical stage, privately held, immuno-oncology company.
NanOlogy
NanOlogy™ is a clinical-stage oncology company
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Paragon Genomics, Inc.
provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
The Honeycomb Clinic
Medical Co-Working Space
uMobile
UMobile is an application developing company.
Current Employees Featured
Founder
Stock Details
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Post-IPO Equity - IMV
Lumira Ventures
Lumira Ventures investment in Post-IPO Equity - IMV
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Post-IPO Equity - IMV
Official Site Inspections
http://www.imv-inc.com Semrush global rank: 1.19 M Semrush visits lastest month: 25.9 K
- Host name: 104.21.92.162
- IP address: 104.21.92.162
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "IMV"
IMV Inc - Crunchbase Company Profile & Funding
IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s …See details»
IMV Inc. - LinkedIn
IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform: the DPX® technology.See details»
Investor Relations :: IMV Inc. (IMV)
IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and …See details»
IMV Inc. (IMVIF) Company Profile & Description - Stock Analysis
Mar 4, 2025 IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX, an immune-educating technology platform for …See details»
Court grants creditor protection to N.S. company developing …
IMV said it had enough drug supply to ensure patients already in screening or enrolled in ongoing trials before May 1 will be able to receive treatment. The company has received more than $5 ...See details»
Annual Report - IMV CORPORATION
Feb 14, 2025 IMV EUROPE LIMITED. 1 Dunsbridge Business Park, Shepreth, Royston, Herts, SG8 6RA, UKSee details»
Corporate Information - IMV CORPORATION
IMV contributes to the safety and security of the world through its business and contributes to the realization of a sustainable society. View More. Corporate Outline. This section includes a …See details»
IMV Inc. - Canada.ca
Out of that innovation grew IMV Inc., and a potential cure for many cancers. “We are now one of the most advanced companies in the world working on immunotherapy,” says the Halifax …See details»
IMV Inc. Announces Strategic Reorganization - BioSpace
Sep 15, 2022 IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform, DPX ®. Through a …See details»
Immunovaccine Announces 2009 Year End Results :: IMV Inc. (IMV)
HALIFAX, NOVA SCOTIA -- (MARKET WIRE) -- 04/19/10 -- Immunovaccine Inc. (TSX VENTURE: IMV) ("Immunovaccine" or the "Company"), a vaccine development company, …See details»
IMV Appoints Andrew Hall as Chief Executive Officer - IMV Inc.
Dec 22, 2021 DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- IMV Inc. (NASDAQ: IMV; TSX: IMV), (“IMV” or “the Company”), a clinical-stage company …See details»
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL …
VANCOUVER, BC, Feb. 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has …See details»
BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL …
VANCOUVER, BC, Feb. 21, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has completed the …See details»
IMV Inc. | LinkedIn
IMV Inc. | 3,950 followers on LinkedIn. Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers | IMV Inc. is a clinical …See details»
IMV Inc. Provides Clinical and Operational Update and Announces …
IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results. Phase 2 SPiReL study of DPX-Survivac combination regimen with Keytruda® in r/r …See details»
Immunovaccine and Leidos Expand Collaboration to Develop …
HALIFAX, Nova Scotia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immunotherapy and vaccine company, today announced …See details»
Working at IMV Inc: Employee Reviews | Indeed.com
Nov 13, 2024 Reviews from IMV Inc employees about IMV Inc culture, salaries, benefits, work-life balance, management, job security, and more.See details»
Filed by e3 Filing, Computershare 1-800-973-3274 - IMV Inc.
IMV Inc. (Name of registrant) 130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia B3B 2C4, Canada ... is also an active member of the research organization Society of Gynecologic …See details»
Imv Inc: Et si on réalisait enfin la promesse de fabriquer des …
IMV Inc. est une société d’immuno-oncologie au stade clinique qui a des installations à Dartmouth (Nouvelle-Écosse) et à Boston (Massachusetts). IMV développe un portefeuille de thérapies …See details»
IMV to Host a Key Opinion Leader Webcast on the Ovarian Cancer ...
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and …See details»